What is NDC 0019-1323?

0019-1323 is the product NDC for Optiray 320 (ioversol), Ioversol 678 mg/mL injection, listed with the FDA by Liebel-Flarsheim Company LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Liebel-Flarsheim Company LLC, NDC labeler code 0019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Optiray 320?

2 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Optiray 320 NDC 0019-1323 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0019-1323Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00019-1323Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0019-1323-65	00019132365	6 BOTTLE, GLASS in 1 CARTON (0019-1323-65) / 500 mL in 1 BOTTLE, GLASSMarketed from Nov 18, 2020

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Optiray 320Suffix: 320
Generic name (nonproprietary): ioversol
Active ingredients: Ioversol — 678 mg/mL
Dosage form: Injection
Route: Intra-arterial, Intravenous
Labeler: Liebel-Flarsheim Company LLCNDC labeler code 0019
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020923
Marketing start: Nov 18, 2020
Listing expires: Dec 31, 2026
Other FDA classes: X-Ray Contrast Activity (Mechanism)
Identifiers: Product ID 0019-1323_471b778f-d9cc-ff10-e063-6394a90a27c9SPL ID 471b778f-d9cc-ff10-e063-6394a90a27c9SPL set ID cd718d1c-f813-4114-a50d-c744ff7eb1bfUNII N3RIB7X24KUPC 0300191332653, 0300191323651, 0300191333650
Pharmacologic class: Radiographic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400019132365 followed by a unit qualifier and the quantity

Package 00019-1323-65. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

OPTIRAY is indicated for: OPTIRAY is a radiographic contrast agent indicated for the following: Intra-arterial Procedures ( 1.1 ) Adults: Cerebral Arteriography (320 mg iodine/mL) Peripheral Arteriography (320, 350 mg iodine/mL ) Visceral and Renal Arteriography, Aortography (320 mg iodine/mL) Coronary Arteriography and Left Ventriculography (320, 350 mg iodine/mL) Pediatric Patients: Angiocardiography (320, 350 mg iodine/mL) Intravenous Procedures ( 1.2 ) Adults: Computed tomography (CT) Imaging of Head and Body (320, 350 mg iodine/mL) Venography (320, 350 mg iodine/mL) Intravenous Excretory Urography (320, 350 mg iodine/mL) Intravenous Digital Subtraction Angiography (350 mg iodine/mL) Ped…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0019-1323

What is NDC 0019-1323?: 0019-1323 is the product NDC for Optiray 320 (ioversol), Ioversol 678 mg/mL injection, listed with the FDA by Liebel-Flarsheim Company LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Optiray 320 (Ioversol).
What is the active ingredient?: Ioversol.
Who is the labeler?: Liebel-Flarsheim Company LLC, NDC labeler code 0019. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Optiray 320?: 2 other product NDCs are listed under this name. See all Optiray 320 NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 020923

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020923
Product	Strength	Form · route	Labeler	Product NDC
Optiray 350ioversol	Ioversol 741 mg/mL	InjectionIntra-arterial, Intravenous	Liebel-Flarsheim Company LLC	0019-1333
Optiray 350ioversol	Ioversol 741 mg/mL	InjectionIntra-arterial, Intravenous	Liebel-Flarsheim Company LLC	0019-1333

Optiray 320 (Ioversol) NDC 0019-1323